Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study

NCT06037239 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous T-cell Lymphoma

Interventions

DRUG: Linperlisib in combined with Chidamide

Sponsor

Peking Union Medical College Hospital